EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Microenvironment-Responsive 6-Mercaptopurine-Releasing Injectable Hydrogel for Colon Cancer Treatment

Sungjun Kim, Wonjeong Lee, Heewon Park, Kyobum Kim iD

Gels · 10.04.2023 · 9 (4) · 319

DOI: 10.3390/gels9040319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 10.04.2023. Verfasst von Sungjun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical & Biochemical Engineering, Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul 22012, Republic of Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine (KFRM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer is a significant health concern. The development of effective drug delivery systems is critical for improving treatment outcomes. In this study, we developed a drug delivery system for colon cancer treatment by embedding 6-mercaptopurine (6-MP), an anticancer drug, in a thiolated gelatin/polyethylene glycol diacrylate hydrogel (6MP-GPGel). The 6MP-GPGel continuously released 6-MP, the anticancer drug. The release rate of 6-MP was further accelerated in an acidic or glutathione environment that mimicked a tumor microenvironment. In addition, when pure 6-MP was used for treatment, cancer cells proliferated again from day 5, whereas a continuous supply of 6-MP from the 6MP-GPGel continuously suppressed the survival rate of cancer cells. In conclusion, our study demonstrates that embedding 6-MP in a hydrogel formulation can improve the efficacy of colon cancer treatment and may serve as a promising minimally invasive and localized drug delivery system for future development.

Schlagwörter

Stichwörter der Autor:innen

6-mercaptopurineanticancercolon cancerdrug delivery systemhydrogel

Autor:innen und Institutionen

  • Department of Chemical & Biochemical Engineering, Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul 22012, Republic of Korea.

ORCID-Profile: Kyobum Kim

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine (KFRM)

Zitieren

APA

Kim, S., Lee, W., Park, H., & Kim, K. (2023). Tumor Microenvironment-Responsive 6-Mercaptopurine-Releasing Injectable Hydrogel for Colon Cancer Treatment. Gels, 9(4), 319. https://doi.org/10.3390/gels9040319

Vancouver

Kim S, Lee W, Park H, Kim K. Tumor Microenvironment-Responsive 6-Mercaptopurine-Releasing Injectable Hydrogel for Colon Cancer Treatment. Gels. 2023;9(4):319. doi:10.3390/gels9040319

BibTeX
@article{Kim2023,
  author = {Kim, Sungjun and Lee, Wonjeong and Park, Heewon and Kim, Kyobum},
  title = {Tumor Microenvironment-Responsive 6-Mercaptopurine-Releasing Injectable Hydrogel for Colon Cancer Treatment},
  journal = {Gels},
  year = {2023},
  volume = {9},
  number = {4},
  pages = {319},
  doi = {10.3390/gels9040319}
}
Kostenlos starten →